[zrn900]

Yet still, Pfizer ended up dominating both markets - by delaying the approval of those that could compete and the lobbying making it so that it was the one that was bulk purchased in quantity.

When I meant approval, I meant the approval of any competitor who could provide at scale. None such vaccine was allowed until the quarantine ended. Even after that Pfizer was still being pushed against all competitors including cheaper American ones. So long story short - their lobby won.